Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Nov;35(11):1363-76.
doi: 10.1038/ijo.2011.2. Epub 2011 Feb 22.

Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis

A N Fabricatore  1 , T A Wadden, A J Higginbotham, L F Faulconbridge, A M Nguyen, S B Heymsfield, M S Faith
Affiliations
Meta-Analysis

Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis

A N Fabricatore et al. Int J Obes (Lond). 2011 Nov.

Abstract

Objective: Obesity is related to increased risk of several health complications, including depression. Many studies have reported improvements in mood with weight loss, but results have been equivocal. The present meta-analysis examined changes in symptoms of depression that were reported in trials of weight loss interventions. Between-groups comparisons of different weight loss methods (for example, lifestyle modification, diet-alone and pharmacotherapy) were examined, as were within-group changes for each treatment type.

Method: MEDLINE was searched for articles published between 1950 and January 2009. Several obesity-related terms were intersected with terms related to depression. Results were filtered to return only studies of human subjects, published in English. Of 5971 articles, 394 were randomized controlled trials. Articles were excluded if they did not report mean changes in weight or symptoms of depression, included children or persons with psychiatric disorders (other than depression), or provided insufficient data for analysis. Thirty-one studies (n=7937) were included. Two authors independently extracted a description of each study treatment, sample characteristics, assessment methods and changes in weight and symptoms of depression. Treatments were categorized as lifestyle modification, non-dieting, dietary counseling, diet-alone, exercise-alone, pharmacotherapy, placebo or control interventions.

Results: Random effects models found that lifestyle modification was superior to control and non-dieting interventions for reducing symptoms of depression, and marginally better than dietary counseling and exercise-alone programs. Exercise-alone programs were superior to controls. No differences were found for comparisons of pharmacologic agents and placebos. Within-group analyses found significant reductions in symptoms of depression for nearly all active interventions. A meta-regression found no relationship between changes in weight and changes in symptoms of depression in lifestyle modification interventions.

Conclusions: On average, obese individuals in weight loss trials experienced reductions in symptoms of depression. Future studies should examine incidence and resolution of clinically significant depressive disorders with weight loss interventions.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

Fabricatore has served as a consultant for Pfizer, Merck, and Ethicon-Endosurgery, and has received research support (including funding for this study) from Merck. Although he is now employed by Nutrisystem, Inc., Fabricatore was employed full-time at the University of Pennsylvania (where he retains an adjunct appointment) at the time the study was completed. Wadden serves on the Advisory Boards of Novo Nordisk and Orexigen and has received research support from Orexigen and Pfizer. Nguyen is employed by Merck and Heymsfield was employed by Merck at the time the work was completed. Faith has served as a consultant to, and has received research support from, Merck. The other authors have no potential conflicts to declare.

Figures

Figure 1
Figure 1
Results of meta-analyses comparing reductions in symptoms of depression with lifestyle modification vs. control (Panel A), non-dieting (Panel B), dietary counseling (Panel C), and exercise-alone (Panel D) interventions. A positive standardized mean difference (SMD) indicates a greater reduction in symptoms of depression with lifestyle modification. The sizes of individual study markers are proportional to the weight of the corresponding study in the analyses. The midpoint of the diamond marker in each analysis represents the overall SMD, and the width of the diamond corresponds to the 95% CI. Note, Wadden (64) (Panel B) compared a non-dieting program to lifestyle modification programs with daily calorie targets of 1000 kcal/day (a) and 1200–1500 kcal/day (b). Williamson (65) (Panel C) compared a lifestyle modification program with dietary counseling interventions that induced a 25% energy deficit (a) and one that provided 890 kcal/day.
Figure 2
Figure 2
Meta-analysis comparing exercise-alone with control interventions. A positive standardized mean difference (SMD) indicates a greater reduction in symptoms of depression with exercise. The size of individual study markers is proportional to the weight of that study in the analysis. Sarsan (55) compared aerobics (a) and resistance (b) training programs to controls. The midpoint of the diamond marker represents the overall SMD, and the width of the diamond corresponds to the 95% CI.
Figure 3
Figure 3
Meta-analysis comparing pharmacologic interventions with placebo. The abbreviations “Sib,” “Orl,” and “Rim” refer to sibutramine, orlistat, and rimonabant, respectively. The dosage of rimonabant (mg/d) also is shown. A positive standardized mean difference (SMD) indicates a greater reduction in symptoms of depression with pharmacotherapy. The size of individual study markers is proportional to the weight of that study in the analysis. The midpoint of the diamond marker represents the overall SMD, and the width of the diamond corresponds to the 95% CI.
See this image and copyright information in PMC

References

    1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–241. - PubMed
    1. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults--The Evidence Report. Obes Res. 1998;6 suppl 2:51S–209S. - PubMed
    1. Flegal KM, Graubard BI, Williamson DF, Gail MH. Impact of smoking and preexisting illness on estimates of the fractions of deaths associated with underweight, overweight, and obesity in the US population. Am J Epidemiol. 2007;166:975–982. - PubMed
    1. Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63:824–830. - PMC - PubMed
    1. Petry NM, Barry D, Pietrzak RH, Wagner JA. Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med. 2008;70:288–297. - PubMed

Publication types